{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:57:46Z","timestamp":1790859466039,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tem.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:25:57Z","timestamp":1779769557000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["X-chromosome gene dosage shapes MASLD beyond sex hormones"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-9989","authenticated-orcid":false,"given":"Mohamad","family":"Jamalinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-0698","authenticated-orcid":false,"given":"Amedeo","family":"Lonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2026.05.001_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2026.05.001_bb0010","article-title":"Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directions","volume":"62","author":"Huang","year":"2026","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.tem.2026.05.001_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.20517\/mtod.2025.131","article-title":"Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions","volume":"5","author":"Jamalinia","year":"2025","journal-title":"Metab. Target Organ Damage"},{"key":"10.1016\/j.tem.2026.05.001_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20517\/mtod.2025.193","article-title":"Biological determinants and outcomes of sex discrepancies in MASLD","volume":"6","author":"Lonardo","year":"2026","journal-title":"Metab. Target Organ Damage"},{"key":"10.1016\/j.tem.2026.05.001_bb0025","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.3390\/ijms26199594","article-title":"Sex hormones and metabolic dysfunction-associated steatotic liver disease","volume":"26","author":"Weiskirchen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.001_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2026.05.001_bb0035","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.tem.2026.05.001_bb0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2026.05.001_bb0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.tem.2026.05.001_bb0050","first-page":"226","article-title":"Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine","volume":"22","author":"Stefan","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2026.05.001_bb0055","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.molmed.2024.05.013","article-title":"Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Cherubini","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2026.05.001_bb0065","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1111\/dom.16568","article-title":"Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: a meta-analysis","volume":"27","author":"Jamalinia","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.48946","article-title":"Sex differences in adverse liver and nonliver outcomes in steatotic liver disease","volume":"7","author":"Yan","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2026.05.001_bb0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5534\/wjmh.240066","article-title":"Testosterone replacement therapy can improve a biomarker of liver fibrosis in hypogonadal men: a subanalysis of a prospective randomized controlled study in Japan (EARTH study)","volume":"43","author":"Shigehara","year":"2025","journal-title":"World J. Mens Health"},{"key":"10.1016\/j.tem.2026.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/apa.70026","article-title":"Sex differences in body composition and MASLD in children with overweight and obesity","volume":"114","author":"Uretzky","year":"2025","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.tem.2026.05.001_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2025.08.007","article-title":"Sex-related variations in liver homeostasis and disease: from zonation dynamics to clinical implications","volume":"84","author":"Matz-Soja","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tem.2026.05.001_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/epigenomes7040029","article-title":"Out of the silence: insights into how genes escape X-chromosome inactivation","volume":"7","author":"Peeters","year":"2023","journal-title":"Epigenomes"},{"key":"10.1016\/j.tem.2026.05.001_bb0095","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1073\/pnas.1910003117","article-title":"Integrated functional genomic analyses of Klinefelter and Turner syndromes reveal global network effects of altered X chromosome dosage","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2026.05.001_bb0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.tem.2023.07.003","article-title":"The impact of chromosomal sex on cardiometabolic health and disease","volume":"34","author":"Wiese","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0105","first-page":"39","article-title":"Burden of liver disease among individuals with Turner syndrome and Klinefelter syndrome: a comprehensive perspective","volume":"12","author":"Jamalinia","year":"2026","journal-title":"Chron. Dis. Transl. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10020-025-01404-1","article-title":"Sex chromosome aneuploidy impacts on human gene expression and regulation: a systematic review","volume":"32","author":"Legue","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0115","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2009-0384","article-title":"X-chromosome gene dosage and the risk of diabetes in Turner syndrome","volume":"94","author":"Bakalov","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-18-0878","article-title":"X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood","volume":"180","author":"Fiot","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.001_bb0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000477761","article-title":"Increased non-high-density lipoprotein cholesterol in children and young adults with Turner syndrome is not explained by BMI alone","volume":"88","author":"Kelley","year":"2017","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.tem.2026.05.001_bb0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cen.13394","article-title":"The Turner syndrome life course project: Karyotype-phenotype analyses across the lifespan","volume":"87","author":"Cameron-Pimblett","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.001_bb0135","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/clinem\/dgaf619","article-title":"Metabolism and type 2 diabetes across life stages in Klinefelter syndrome: a population-based cohort study","volume":"111","author":"Chang","year":"2026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0145","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1093\/ejendo\/lvae050","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome","volume":"190","author":"Gravholt","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.001_bb0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.eprac.2023.11.013","article-title":"Abnormal body composition increases the cardiometabolic risk in adolescents and young adults with Turner syndrome","volume":"30","author":"Mondal","year":"2024","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.tem.2026.05.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0031","article-title":"Reproductive hormones, bone mineral content, body composition, and testosterone therapy in boys and adolescents with Klinefelter syndrome","volume":"12","author":"L\u00f3pez Krabbe","year":"2023","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.tem.2026.05.001_bb0160","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s40618-020-01299-1","article-title":"Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis","volume":"43","author":"Pizzocaro","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.tem.2026.05.001_bb0165","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s40618-024-02394-3","article-title":"Mild liver dysfunction in Klinefelter syndrome is associated with abdominal obesity and elevated lipids but not testosterone treatment","volume":"47","author":"\u00d8zdemir","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.tem.2026.05.001_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1116889","article-title":"Hyperglycemia in Turner syndrome: impact, mechanisms, and areas for future research","volume":"14","author":"Mitsch","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.001_bb0175","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1210\/clinem\/dgae357","article-title":"Characterization of Turner syndrome-associated diabetes mellitus","volume":"110","author":"Cameron-Pimblett","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fendo.2020.00482","article-title":"Insulin sensitivity and pancreatic \u03b2-cell function in Ecuadorian women with Turner syndrome","volume":"11","author":"\u00c1lvarez-Nava","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2026.05.001_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000520233","article-title":"Increased prevalence of beta-cell dysfunction despite normal HbA1c in youth and young adults with Turner syndrome","volume":"94","author":"Sheanon","year":"2021","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.tem.2026.05.001_bb0190","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.fertnstert.2012.07.1122","article-title":"Prevalence and risk factors of diabetes in patients with Klinefelter syndrome: a longitudinal observational study","volume":"98","author":"Jiang-Feng","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2026.05.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad124","article-title":"A prospective study of lipids in adult women with Turner syndrome","volume":"7","author":"Sandahl","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.tem.2026.05.001_bb0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajmg.c.31792","article-title":"Metabolic and cardiovascular risk factors in Klinefelter syndrome","volume":"184","author":"Spaziani","year":"2020","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.tem.2026.05.001_bb0205","doi-asserted-by":"crossref","first-page":"e1564","DOI":"10.1210\/clinem\/dgad730","article-title":"From Klinefelter syndrome to high grade aneuploidies: expanding the gene-dosage effect of supernumerary X chromosomes","volume":"109","author":"Spaziani","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41371-022-00777-8","article-title":"The prevalence of hypertension in paediatric Turner syndrome: a systematic review and meta-analysis","volume":"37","author":"McCarrison","year":"2023","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tem.2026.05.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0477","article-title":"Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry","volume":"14","author":"Mathara Diddhenipothage","year":"2025","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.tem.2026.05.001_bb0220","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/HYPERTENSIONAHA.120.15292","article-title":"Natural history of hypertension in Turner syndrome during a 12-year pragmatic interventional study","volume":"76","author":"Sandahl","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2026.05.001_bb0225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/apt.70457","article-title":"Meta-analysis: liver disease burden and associated factors in Turner syndrome","volume":"63","author":"Jamalinia","year":"2026","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.tem.2026.05.001_bb0230","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1210\/clinem\/dgac056","article-title":"Population-based assessment of cardiometabolic-related diagnoses in youth with Klinefelter syndrome: a PEDSnet study","volume":"107","author":"Davis","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf059","article-title":"Elevated liver enzymes in Turner syndrome: the role of low-grade inflammation and hormonal imbalances","volume":"9","author":"Ridder","year":"2025","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.tem.2026.05.001_bb0240","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1210\/clinem\/dgaf479","article-title":"Metabolic dysfunction-associated steatotic liver disease in Klinefelter syndrome: high prevalence uncovers an unmet need","volume":"111","author":"Marrone","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1452","article-title":"KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression","volume":"13","author":"Guo","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13293-026-00844-6","article-title":"KDM5C and KDM5D influence DNA methylation in adult mouse liver","volume":"17","author":"Gibbons","year":"2026","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.tem.2026.05.001_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.912727","article-title":"A dual role of DDX3X in dsRNA-derived innate immune signaling","volume":"9","author":"Kwon","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tem.2026.05.001_bb0260","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.15278","article-title":"The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathway","volume":"42","author":"Liu","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2026.05.001_bb0265","article-title":"PNPLA-mediated lipid hydrolysis and transacylation \u2013 at the intersection of catabolism and anabolism","volume":"1869","author":"Cola\u00e7o-Gaspar","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.tem.2026.05.001_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16133","article-title":"Impact of PNPLA3 I148M on clinical outcomes in patients with MASLD","volume":"45","author":"Petta","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2026.05.001_bb0275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/17501911.2026.2633978","article-title":"Epigenetic regulation in MASLD - insight for therapeutic target discovery","volume":"18","author":"Britsemmer","year":"2026","journal-title":"Epigenomics"},{"key":"10.1016\/j.tem.2026.05.001_bb0280","doi-asserted-by":"crossref","first-page":"43","DOI":"10.20517\/mtod.2024.75","article-title":"Epigenetic and epitranscriptomic regulations of metabolic dysfunction-associated steatotic liver disease","volume":"4","author":"Zheng","year":"2024","journal-title":"Metab. Target Organ Damage"},{"key":"10.1016\/j.tem.2026.05.001_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-025-00780-3","article-title":"Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Boel","year":"2025","journal-title":"Commun. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0290","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","article-title":"The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Sawada","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107980","article-title":"Mitochondrial damage-associated molecular patterns (mito-DAMPs): determinants of hepatopathy progression and therapeutic implications","volume":"221","author":"Luo","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tem.2026.05.001_bb0300","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/antiox13080906","article-title":"Altered mitochondrial function in MASLD: key features and promising therapeutic approaches","volume":"13","author":"Radosavljevic","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.tem.2026.05.001_bb0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo16010025","article-title":"Associations between systemic inflammatory markers, metabolic dysfunction, and liver fibrosis scores in patients with MASLD","volume":"16","author":"Eid","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.tem.2026.05.001_bb0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13679-025-00657-5","article-title":"The intriguing roles of cytokines in metabolic dysfunction-associated steatotic liver disease: a narrative review","volume":"14","author":"Vachliotis","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.tem.2026.05.001_bb0315","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis","volume":"26","author":"Martin","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tem.2026.05.001_bb0320","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102701","article-title":"A whole-organism landscape of X-inactivation in humans","volume":"14","author":"Gylemo","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.tem.2026.05.001_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000044519","article-title":"Evaluating and predicting Klinefelter and Turner syndrome burden in China from 1990 to 2021: a study based on the global burden of disease database","volume":"104","author":"Shen","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tem.2026.05.001_bb0330","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/jcm15031088","article-title":"Determinants of health-related quality of life in women with Turner syndrome: the role of comorbidities, hormonal therapy and depressive symptoms","volume":"15","author":"Krzy\u015bcin","year":"2026","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tem.2026.05.001_bb0335","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1210\/clinem\/dgaf261","article-title":"Update on physical, psychological, and quality of life management in Klinefelter syndrome","volume":"110","author":"Mehmet","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.001_bb0340","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cgh.2025.06.036","article-title":"FIB-4-based referral pathways have suboptimal accuracy to identify increased liver stiffness and incident advanced liver disease","volume":"24","author":"van Kleef","year":"2026","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026001207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026001207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:15:26Z","timestamp":1779999326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276026001207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"alternative-id":["S1043276026001207"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2026.05.001","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"X-chromosome gene dosage shapes MASLD beyond sex hormones","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}